The WHO rules encourage the adoption of these systems, supplied they can be validated to demonstrate equal or exceptional efficiency as compared to regular procedures. Manufacturers wanting to employ these methods have to present strong validation data to exhibit their equivalence to pharmacopoeial strategies. Meant to satisfy the require